Study site procedure describing how to collect and report safety data. 

Study site procedure describing how to collect and report safety data including serious adverse events, adverse events of special interest, pregnancies, overdoses and also periodic reports and safety signals. Reporting to the Sponsor pharmacovigilance unit, Ethics Committees, Data and Safety Monitoring Boards, National Regulatory Agencies is described.

Target user: Study coordinators and TB doctors (investigators)